Cabergoline
- PDF / 168,815 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 70 Downloads / 176 Views
1 S
Hypersexuality: case report In a multicenter cross-sectional study of 212 patients from April 2017 to December 2018, a man [age not stated] was described, who developed hypersexuality during treatment with cabergoline [Dostinex] for hyperprolactinemia [route, dosage, duration of treatment to reaction onset and outcome not stated]. He was separated from his wife (decades) after being on cabergoline. De Sousa SMC, et al. Impulse Control Disorders in Dopamine Agonist-Treated Hyperprolactinemia: Prevalence and Risk Factors. Journal of Clinical Endocrinology and 803520609 Metabolism 105: e108-e118, No. 3, Mar 2020. Available from: URL: http://doi.org/10.1210/clinem/dgz076
0114-9954/20/1834-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 12 Dec 2020 No. 1834
Data Loading...
